Literature DB >> 12115621

BAFF is a survival and maturation factor for mouse B cells.

Antonius G Rolink1, Jürg Tschopp, Pascal Schneider, Fritz Melchers.   

Abstract

Human B cell-activating factor (BAFF) induces mouse surface IgM+ B cells of the immature type from bone marrow and of the immature types 1 and 2 from spleen, as well as of the mature type from spleen to increased longevity in tissue culture. BAFF does so polyclonally and without inducing proliferation in any of these B cell subpopulations. BAFF induces phenotypic and functional maturation of immature to mature B cells so that all immature cells loose C1qRp (AA4.1, 493) expression and type 1 immature cells up-regulate IgD, CD21 and CD23. Immature B cells of types 1 and 2, upon pre-incubation with BAFF, change their reactiveness to Ig-specific antibodies so that they no longer enter apoptosis but now proliferate. However, BAFF does not seem to overcome negative selection of developing immature B cells in vitro.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12115621     DOI: 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  46 in total

1.  Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus.

Authors:  William Stohl; Falk Hiepe; Kevin M Latinis; Mathew Thomas; Morton A Scheinberg; Ann Clarke; Cynthia Aranow; Frank R Wellborne; Carlos Abud-Mendoza; Douglas R Hough; Lilia Pineda; Thi-Sau Migone; Z John Zhong; William W Freimuth; W Winn Chatham
Journal:  Arthritis Rheum       Date:  2012-07

2.  3BP2 deficiency impairs the response of B cells, but not T cells, to antigen receptor ligation.

Authors:  Miguel A de la Fuente; Lalit Kumar; Bao Lu; Raif S Geha
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

Review 3.  Checkpoints that control B cell development.

Authors:  Fritz Melchers
Journal:  J Clin Invest       Date:  2015-05-04       Impact factor: 14.808

4.  BOB.1/OBF.1 deficiency affects marginal-zone B-cell compartment.

Authors:  Tatjana Samardzic; Dragan Marinkovic; Peter J Nielsen; Lars Nitschke; Thomas Wirth
Journal:  Mol Cell Biol       Date:  2002-12       Impact factor: 4.272

5.  Astrocyte-derived CXCL10 drives accumulation of antibody-secreting cells in the central nervous system during viral encephalomyelitis.

Authors:  Timothy W Phares; Stephen A Stohlman; David R Hinton; Cornelia C Bergmann
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

Review 6.  Checkpoints in lymphocyte development and autoimmune disease.

Authors:  Harald von Boehmer; Fritz Melchers
Journal:  Nat Immunol       Date:  2009-12-17       Impact factor: 25.606

7.  Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; William J Quinn; Michael P Cancro; Huaxin Gao; Chaim Putterman; Xiaoni Gao; Luminita Pricop; Michael N Koss
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  High-dose dexamethasone inhibits BAFF expression in patients with immune thrombocytopenia.

Authors:  Xiao-juan Zhu; Yan Shi; Jian-zhi Sun; Ning-ning Shan; Jun Peng; Cheng-shan Guo; Ping Qin; Ming Hou
Journal:  J Clin Immunol       Date:  2009-06-05       Impact factor: 8.317

9.  Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.

Authors:  Chaim O Jacob; Ning Yu; Shunhua Guo; Noam Jacob; William J Quinn; Vishal Sindhava; Michael P Cancro; Beatrice Goilav; Chaim Putterman; Thi-Sau Migone; William Stohl
Journal:  Arthritis Rheum       Date:  2013-04

10.  Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells.

Authors:  Melanie Rauch; Roxane Tussiwand; Nabil Bosco; Antonius G Rolink
Journal:  PLoS One       Date:  2009-05-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.